(19)
(11) EP 1 165 517 A1

(12)

(43) Date of publication:
02.01.2002 Bulletin 2002/01

(21) Application number: 00918516.6

(22) Date of filing: 31.03.2000
(51) International Patent Classification (IPC)7C07D 235/14, C07D 209/14, A61K 31/4184, A61K 31/4045, A61P 25/00, G01N 33/50
(86) International application number:
PCT/US0008/570
(87) International publication number:
WO 0059/888 (12.10.2000 Gazette 2000/41)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 02.04.1999 US 127624 P
02.04.1999 US 285420

(71) Applicant: NEUROGEN CORPORATION
Branford, CT 06405 (US)

(72) Inventors:
  • HORVATH, Raymond, F.
    North Branford, CT 06471 (US)
  • GE, Ping
    Branford, CT 06405 (US)
  • YOON, Taeyoung
    East Haven, CT 06512 (US)
  • HUTCHISON, Alan
    Madison, CT 06443 (US)

(74) Representative: Smaggasgale, Gillian Helen et al
W.P. Thompson & Co, Celcon House, 289-293 High Holborn
London WC1V 7HU
London WC1V 7HU (GB)

   


(54) N-BENZIMIDAZOLYLMETHYL- AND N-INDOLYLMETHYL-BENZAMIDES AND THEIR USE AS CRF MODULATORS